Related Experiment Videos
Cost-effectiveness of widespread screening for Chlamydia trachomatis
Maarten J Postma1, Robert Welte, Servaas A Morré
1Groningen University Institute for Drug Exploration/university of Groningen Research Institute of Pharmacy (GUIDE/GRIP), Groningen, The Netherlands.
Expert Opinion on Pharmacotherapy
|October 22, 2002
Summary
Widespread screening for Chlamydia trachomatis in women is being considered to prevent infertility and ectopic pregnancy. This review examines screening goals, treatments, and economic factors, using Dutch data as an example.
Area of Science:
- Public Health
- Infectious Diseases
- Gynecology
Background:
- Sexually transmitted disease (STD) screening is part of routine healthcare in Western Europe.
- Chlamydia trachomatis screening is being considered for expansion.
- Chlamydia trachomatis infections in women can lead to infertility and ectopic pregnancy.
Purpose of the Study:
- To review the objectives of Chlamydia trachomatis screening and treatment.
- To discuss available diagnostic and therapeutic compounds.
- To analyze current best practices, focusing on economic performance and influencing factors.
Main Methods:
- Literature review of screening strategies and therapeutic options.
- Economic analysis of screening programs.
- Case study from The Netherlands.
Main Results:
- Chlamydia trachomatis screening aims to reduce long-term health consequences.
- Various compounds are available for testing and treatment.
- Economic viability is a crucial factor in implementing widespread screening.
Conclusions:
- Effective screening and treatment strategies for Chlamydia trachomatis are essential for women's health.
- Economic considerations significantly impact the feasibility of expanded screening programs.
- The findings from The Netherlands offer insights applicable to other regions.